← All trials
NCT02907554
Phase 4Interventional
Studies of FDA-approved drugs to delineate additional information including the drug's risks, benefits, and optimal use.
View on ClinicalTrials.gov ↗Timeline
- Start date
- Sep 1, 2016
- Primary completion
- Mar 1, 2018
- Completion date
- Mar 1, 2018
- First posted
- —
- Last posted
- —
- Enrollment
- 648
- Arms / groups
- 2 / —
- Source
- AACT · pre-existing
Sponsors
- University Clermont AuvergneLead sponsor
- Centre Hospitalier Universitaire de NīmesCollaborator
- University of ToulouseCollaborator
- University of ParisCollaborator
- University of Nice Sophia AntipolisOverall official - principal investigator
- University of Nice Sophia AntipolisCollaborator
- University Hospital, EstaingCollaborator
- University of MontpellierCollaborator
- University of PoitiersCollaborator
Drugs studied
Indications studied
CDEK-curated fields only — the ClinicalTrials.gov results mirror (baseline measures, adverse events, participant flow) is a separate, currently-dormant pipeline; see MIGRATION_PLAN.md.